Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11,382 GBX | +1.01% | +4.25% | +6.83% |
Apr. 23 | AstraZeneca's Voydeya Approved as Add-on Therapy in Europe for Blood Disorder | MT |
Apr. 23 | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
- Stock Market
- Equities
- AZN Stock
- News AstraZeneca PLC